No fresh guidelines on Covid, no panic, say health officials
Covid-19 guidelines
or protocols at present.
Officials received instructions to maintain calm and avoid causing unnecessary alarm regarding the recent Covid-19 cases reported within the state.
Officials confirmed that the Covid-19-related fatality recorded in Jaipur on Sunday was an isolated incident, linked to co-morbidity, tuberculosis.
In this regard,
Health minister Gajendra Singh Khimsar
held a meeting with health department officials on Tuesday to provide necessary directions.
Khimsar said that according to the Centre, the
current variant of Covid-19
circulating in the country is not lethal, but people should take basic precautions and seek necessary advice, testing, and treatment at medical institutions if they exhibit symptoms like cough, cold, or fever.
Khimsar emphasised that vulnerable groups including elderly, pregnant women, and children should take special care of their health in light of the Covid-19 cases.
If symptoms of influenza-like illness (ILI) appear, they should consult a doctor and avoid crowded places. He instructed officials that although medical experts have not indicated a significant threat from Covid-19 under current circumstances, medical institutions should be prepared with necessary arrangements.
Principal secretary (health) Gayatri Rathore directed the officials to ensure that oxygen plants remain operational and instructed that regular monitoring of oxygen plants established in various medical institutions across the state should be conducted.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
40 minutes ago
- News18
SC adds NHRC to PIL for law on mental health care
Agency: PTI Last Updated: New Delhi, Jul 16 (PTI) The Supreme Court on Friday directed the National Human Right Commission to be made a party to the PIL for the implementation of a 2017 law on safeguarding the rights and needs of persons with mental illnesses. A bench comprising Justices P S Narasimha and Atul S Chandurkar asked petitioner Gaurav Kumar Bansal to file an application to make rights body NHRC a party to the PIL filed in 2018. The bench said the PIL may be transferred to the NHRC for implementing the Mental Healthcare Act, 2017. Bansal said a committee headed by a former apex court judge could be set up to oversee the implementation. 'We cannot create a parallel mechanism just because the existing system has any flaws," the bench said. The bench, in the meantime, asked Additional Solicitor General Aishwarya Bhati, representing the Centre, to share its affidavit with Bansal and posted the hearing after three weeks. The bench had previously said Parliament enacted the Mental Healthcare Act in 2017 which contemplates establishment of 'Central Mental Health Authority (CMHA), State Mental Health Authority (SMHA) and Mental Health Review Board (MHRB)". The top court on March 2 directed Centre to file an affidavit indicating the establishment and functioning of the Central Mental Health Authority, State Mental Health Authority and Mental Health Review Board. The affidavit was further ordered to show the statutory and mandatory appointments to the authority and the review board. On January 3, 2019, the apex court issued notices to the Centre, all states and Union Territories on the petition which has claimed that non-implementation of provisions of the Act by the states and UTs was a gross violation of life and liberty of the citizens. Taking note of an incident, the bench said chaining people with mental illness was violative of their rights under Article 21 of the Constitution, which deals with life and personal liberty, and their dignity cannot be compromised. The PIL argued persons with mental illnesses were chained in a faith-based mental asylum in Budaun district of Uttar Pradesh in violation of provisions of the Mental Health Care Act 2017. The court examined the photos of such patients calling it a matter of great concern. The PIL said chaining a person suffering from mental illness was a blatant violation of a provision of the 2017 Act which says that every such person shall not only have a right to live with dignity but he or she shall be protected from cruel, inhuman and degrading treatment. Referring to the National Mental Health Survey 2016, he has claimed that around 14 per cent of India's population requires active mental health interventions and around 2 per cent Indians were suffering from severe mental disorders. PTI SJK SJK AMK AMK (This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments First Published: July 18, 2025, 13:30 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time of India
2 hours ago
- Time of India
Big relief for central govt employees: CGHS rates to be revised soon, says Union Minister Mansukh Mandaviya
In a move that may provide big relief to central government employees, the Centre may revise the CGHS rates soon. The Centre will soon revise the rates under the Central Government Health Scheme (CGHS) to improve healthcare services, Union Minister for Labour and Employment Dr Mansukh Mandaviya said, a HT report stated. He gave this assurance during a meeting with Maharashtra Health Minister Prakash Ambedkar in New Delhi. The meeting was held to review the status of Employees' State Insurance Scheme (ESIS) hospitals in the state. CGHS rate revisions last year: In September last year, the Ministry of Health and Family Welfare revised the CGHS rates for advanced neuro-implants. The update covered medical devices such as Deep Brain Stimulation (DBS) implants, Intra-Thecal Pumps, and Spinal Cord Stimulators. These implants are used for the treatment of chronic conditions like Parkinson's disease and long-term pain. Explore courses from Top Institutes in Select a Course Category MBA Operations Management PGDM Degree Data Analytics Technology Data Science Product Management Digital Marketing Management Public Policy Healthcare Others Finance healthcare Cybersecurity Data Science CXO Design Thinking others MCA Project Management Leadership Artificial Intelligence Skills you'll gain: Financial Management Team Leadership & Collaboration Financial Reporting & Analysis Advocacy Strategies for Leadership Duration: 18 Months UMass Global Master of Business Administration (MBA) Starts on May 13, 2024 Get Details Skills you'll gain: Analytical Skills Financial Literacy Leadership and Management Skills Strategic Thinking Duration: 24 Months Vellore Institute of Technology VIT Online MBA Starts on Aug 14, 2024 Get Details According to the revised policy, only specialists from government hospitals can prescribe these implants. DBS implants, which target specific areas of the brain to control movement disorders, must be prescribed by a neurologist. Intra-Thecal Pumps and Spinal Cord Stimulators—used for direct delivery of pain relief—require approval from two specialists in neurology or neurosurgery. Final clearance for all such procedures is granted by the CGHS Director. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like No annual fees for life UnionBank Credit Card Apply Now Undo CGHS revised prices for neuro-implants The updated CGHS rates (including GST) are as follows: DBS Non-Rechargeable Device: ₹8.37 lakh to ₹10.32 lakh DBS Rechargeable Device: ₹11.24 lakh to ₹13.89 lakh Intra-Thecal Pump: ₹5.29 lakh Spinal Cord Stimulator: ₹13.90 lakh Live Events These rates apply only to the cost of the implants and do not include expenses for surgery or hospitalization. Supersedes older guidelines The new pricing and approval guidelines issued in September override all earlier circulars released in 2008, 2014, and 2018. This change was aimed at simplifying the approval process and ensuring reimbursement is aligned with current market rates for these advanced medical devices. Ambedkar urges broader ESIS access During the meeting, Ambedkar requested the Union government to raise the income eligibility limit for ESIS beneficiaries from ₹21,000 to ₹30,000 per month. 'This would allow more workers to access the scheme and help expand coverage across the state,' he said. Ambedkar also asked for additional financial support from the Centre to improve healthcare infrastructure and services for workers and their families. The review meeting covered operational challenges and pending construction works at ESIC hospitals in Andheri, Kolhapur, and Ulhasnagar. Pending projects to be fast-tracked Dr Mandaviya assured that the incomplete works at these ESIC hospitals would be completed soon. He said the director-general of ESIC would be directed to prioritise and expedite these projects. He also informed that he would personally visit the ESIS hospital in Andheri with the state health minister. The Union Minister suggested a comprehensive review of all ESIC hospitals in Maharashtra. He added that the Centre was also considering upgrading the ESIC hospital in Nashik in light of the upcoming Kumbh Mela. 'This meeting will boost efforts to strengthen ESIC healthcare facilities across Maharashtra and will help ensure better medical services for insured workers,' said Ambedkar. Current status of ESIS in Maharashtra According to official data, Maharashtra currently has 15 ESIS hospitals, 134 service dispensaries, and 450 empanelled private hospitals. These facilities collectively serve about 4.87 million insured workers and their families—covering nearly two crore people under the scheme. The meeting was also attended by Health Secretary Virendra Singh, ESIS Commissioner Ramesh Chavan, and other senior government officials.
&w=3840&q=100)
First Post
2 hours ago
- First Post
War against cancer: A victory in progress as death rates tumble with new drugs, screening and prevention
The chances of getting affected by cancer increase as people age. Since the 1990s, the age-adjusted death rate related to cancer has fallen considerably read more The fight against cancer has been yielding results slowly and steadily. Data on cancer's manifestations and treatment has painted a positive picture. Could that mean that the world is inching closer to a cure? While an answer to that remains uncertain, other factors, like death rates and advanced medical treatment, suggest that things are looking better than they were a decade ago. Here's how: Falling death rates The chances of getting affected by cancer increase as people age. Since the 1990s, the age-adjusted death rate related to cancer has fallen considerably. For example, in the US, where cancer is the second-most common cause of death, the age-adjusted death rate is now a third lower than in the 1990s. This trend is not exclusive to America, but is mimicked by other developed countries as well. A 2024 report by the Nation on the Status of Cancer shows that overall death rates from cancer declined steadily among both men and women from 2001 through 2022, even during the first two years of the Covid-19 pandemic. STORY CONTINUES BELOW THIS AD Childhood leukaemia survival rates go up The survival rate of childhood leukaemia has increased significantly in the past few years. Now, it has a five-year survival rate above 90 per cent. This has been made possible by advancements in treatment measures for Acute Lymphoblastic Leukaemia (ALL), which is the most common type that affects children. Better prevention One of the most overlooked success stories in the fight against cancer is prevention. For instance, smoking rates have dropped sharply in high-income countries, likely preventing over 3 million cancer deaths in the US alone since 1975. Yet smoking still accounts for one in five cancer deaths globally. This means that anti-tobacco efforts in low- and middle-income countries, where smoking remains widespread, have the potential to save millions more lives. Cheaper treatment Cancer treatment has gone easy on the pockets considerably. Curbing the spread of cervical cancer, the most common cancer among women, is a case in point. Cervical cancer is caused by the delayed side-effect of infection with the human papillomavirus (HPV). Now, the prevalence of the HPV vaccine and its administration to young girls across the world has brought down the chances of getting the bug at all. In the UK, for example, HPV vaccines have brought down the rates of cervical cancer among women in their 20s are down by 90 per cent.
